8-37766296-C-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PM1PM2PP5_Very_Strong
The NM_007198.4(PLPBP):c.260C>T(p.Pro87Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000634 in 1,609,148 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Likely pathogenic (★★).
Frequency
Genomes: 𝑓 0.000033 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000067 ( 0 hom. )
Consequence
PLPBP
NM_007198.4 missense
NM_007198.4 missense
Scores
4
9
5
Clinical Significance
Conservation
PhyloP100: 7.52
Genes affected
PLPBP (HGNC:9457): (pyridoxal phosphate binding protein) This gene encodes a pyridoxal 5'-phosphate binding protein involved in the homeostatic regulation of intracellular pyridoxal 5'-phosphate. This gene has a tumor suppressive effect on hepatocellular carcinoma and other solid tumors of epithelial origin. Naturally occurring mutations in this gene are associated with a pyridoxine-dependent epilepsy. [provided by RefSeq, Mar 2017]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PM1
In a chain Pyridoxal phosphate homeostasis protein (size 274) in uniprot entity PLPHP_HUMAN there are 4 pathogenic changes around while only 1 benign (80%) in NM_007198.4
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 8-37766296-C-T is Pathogenic according to our data. Variant chr8-37766296-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 374856.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-37766296-C-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PLPBP | NM_007198.4 | c.260C>T | p.Pro87Leu | missense_variant | 4/8 | ENST00000328195.8 | NP_009129.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PLPBP | ENST00000328195.8 | c.260C>T | p.Pro87Leu | missense_variant | 4/8 | 1 | NM_007198.4 | ENSP00000333551.3 |
Frequencies
GnomAD3 genomes AF: 0.0000329 AC: 5AN: 152100Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
5
AN:
152100
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000202 AC: 5AN: 247412Hom.: 0 AF XY: 0.00000747 AC XY: 1AN XY: 133830
GnomAD3 exomes
AF:
AC:
5
AN:
247412
Hom.:
AF XY:
AC XY:
1
AN XY:
133830
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000666 AC: 97AN: 1457048Hom.: 0 Cov.: 30 AF XY: 0.0000662 AC XY: 48AN XY: 724842
GnomAD4 exome
AF:
AC:
97
AN:
1457048
Hom.:
Cov.:
30
AF XY:
AC XY:
48
AN XY:
724842
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000329 AC: 5AN: 152100Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74280
GnomAD4 genome
AF:
AC:
5
AN:
152100
Hom.:
Cov.:
32
AF XY:
AC XY:
3
AN XY:
74280
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
1
ALSPAC
AF:
AC:
0
ExAC
AF:
AC:
2
ClinVar
Significance: Pathogenic/Likely pathogenic
Submissions summary: Pathogenic:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 14, 2024 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 87 of the PROSC protein (p.Pro87Leu). This variant is present in population databases (rs755946598, gnomAD 0.008%). This missense change has been observed in individual(s) with clinical features of pyridoxine-dependent epilepsy (PMID: 27912044, 28391250, 29689137, 33766999). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 374856). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt PROSC protein function with a negative predictive value of 80%. Experimental studies are conflicting or provide insufficient evidence to determine the effect of this variant on PROSC function (PMID: 27912044, 29689137). For these reasons, this variant has been classified as Pathogenic. - |
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 01, 2023 | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 29689137, 28914444, 28391250, 27912044, 33766999, 33728241, 36007526, 33425341) - |
Epilepsy, early-onset, vitamin B6-dependent Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Aug 14, 2023 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego | Jan 16, 2020 | This variant has been previously reported as compound heterozygous change and as homozygous change in patients with Epilepsy, early-onset, vitamin B6-dependent (PMID: 27912044, 28391250). Based on complementation studies in PROSC-deficient E. coli the p.Pro87Leu protein appeared to retained some function (PMID: 27912044). Additional functional studies in bacteria showed that the p.Pro87Leu variant results in decreased protein solubility (PMID: 29689137). It is present in the heterozygous state in the gnomAD population database at a frequency of 0.003% (7/278808) and is absent in the homozygous state, thus is presumed to be rare. In silico tools used to predict the effect of this variant on protein function yield discordant results. Based on the available evidence, the c.260C>T (p.Pro87Leu) variant is classified as Likely Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Pathogenic
DANN
Uncertain
DEOGEN2
Benign
T;T;.;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Pathogenic
D
LIST_S2
Pathogenic
D;D;D;D
M_CAP
Benign
T
MetaRNN
Uncertain
D;D;D;D
MetaSVM
Benign
T
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;D;D;D
REVEL
Uncertain
Sift
Uncertain
D;D;D;D
Sift4G
Uncertain
T;T;T;D
Polyphen
B;.;.;.
Vest4
MutPred
Gain of sheet (P = 0.0049);Gain of sheet (P = 0.0049);.;.;
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at